{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T19:40:02Z","timestamp":1746733202583,"version":"3.40.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"crossref","award":["20ck0106537h"],"award-info":[{"award-number":["20ck0106537h"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-025-01207-w","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T22:01:35Z","timestamp":1742940095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Establishment and characterization of NCC-dCS2-C1: a novel patient-derived cell line of dedifferentiated chondrosarcoma"],"prefix":"10.1007","volume":"38","author":[{"given":"Shuhei","family":"Iwata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rei","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yomogi","family":"Shiota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Ohtori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6405-7792","authenticated-orcid":false,"given":"Tadashi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"key":"1207_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15153924","author":"W Zaj\u0105c","year":"2023","unstructured":"Zaj\u0105c W, Dr\u00f3\u017cd\u017c J, Kisielewska W, et al. Dedifferentiated chondrosarcoma from molecular pathology to current treatment and clinical trials. Cancers. 2023. https:\/\/doi.org\/10.3390\/cancers15153924.","journal-title":"Cancers"},{"key":"1207_CR2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41571-021-00521-0","volume":"18","author":"CJ Pirozzi","year":"2021","unstructured":"Pirozzi CJ, Yan H. The implications of IDH mutations for cancer development and therapy. Nat Rev Clin Oncol. 2021;18:645\u201361.","journal-title":"Nat Rev Clin Oncol"},{"key":"1207_CR3","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S1470-2045(05)70282-5","volume":"6","author":"JV Bov\u00e9e","year":"2005","unstructured":"Bov\u00e9e JV, Cleton-Jansen AM, Taminiau AH, Hogendoorn PC. Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. Lancet Oncol. 2005;6:599\u2013607.","journal-title":"Lancet Oncol"},{"key":"1207_CR4","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/path.2913","volume":"224","author":"MF Amary","year":"2011","unstructured":"Amary MF, Bacsi K, Maggiani F, et al. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol. 2011;224:334\u201343.","journal-title":"J Pathol"},{"key":"1207_CR5","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.5858\/arpa.2020-0379-OA","volume":"145","author":"CG Lucas","year":"2021","unstructured":"Lucas CG, Grenert JP, Horvai A. Targeted next-generation sequencing identifies molecular and genetic events in dedifferentiated chondrosarcoma. Arch Pathol Lab Med. 2021;145:1009\u201317.","journal-title":"Arch Pathol Lab Med"},{"key":"1207_CR6","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/j.ejca.2007.06.016","volume":"43","author":"RJ Grimer","year":"2007","unstructured":"Grimer RJ, Gosheger G, Taminiau A, et al. Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group. Eur J Cancer. 2007;43:2060\u20135.","journal-title":"Eur J Cancer"},{"key":"1207_CR7","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1634\/theoncologist.2007-0237","volume":"13","author":"H Gelderblom","year":"2008","unstructured":"Gelderblom H, Hogendoorn PC, Dijkstra SD, et al. The clinical approach towards chondrosarcoma. Oncologist. 2008;13:320\u20139.","journal-title":"Oncologist"},{"key":"1207_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.crad.2003.08.009","volume":"59","author":"A Saifuddin","year":"2004","unstructured":"Saifuddin A, Mann BS, Mahroof S, Pringle JA, Briggs TW, Cannon SR. Dedifferentiated chondrosarcoma: use of MRI to guide needle biopsy. Clin Radiol. 2004;59:268\u201372.","journal-title":"Clin Radiol"},{"key":"1207_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2106\/00004623-199903000-00004","volume":"81","author":"FY Lee","year":"1999","unstructured":"Lee FY, Mankin HJ, Fondren G, et al. Chondrosarcoma of bone: an assessment of outcome. J Bone Jt Surg Am. 1999;81:326\u201338.","journal-title":"J Bone Jt Surg Am"},{"key":"1207_CR10","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.2106\/JBJS.H.00416","volume":"91","author":"AY Giuffrida","year":"2009","unstructured":"Giuffrida AY, Burgueno JE, Koniaris LG, Gutierrez JC, Duncan R, Scully SP. Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. J Bone Jt Surg Am. 2009;91:1063\u201372.","journal-title":"J Bone Jt Surg Am"},{"key":"1207_CR11","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1002\/cncr.21936","volume":"106","author":"EL Staals","year":"2006","unstructured":"Staals EL, Bacchini P, Bertoni F. Dedifferentiated central chondrosarcoma. Cancer. 2006;106:2682\u201391.","journal-title":"Cancer"},{"key":"1207_CR12","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.2106\/00004623-200411000-00008","volume":"86","author":"ID Dickey","year":"2004","unstructured":"Dickey ID, Rose PS, Fuchs B, et al. Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes. J Bone Jt Surg Am. 2004;86:2412\u20138.","journal-title":"J Bone Jt Surg Am"},{"key":"1207_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.otsr.2009.05.004","volume":"95","author":"X Deloin","year":"2009","unstructured":"Deloin X, Dumaine V, Biau D, et al. Pelvic chondrosarcomas: surgical treatment options. Orthop Traumatol Surg Res OTSR. 2009;95:393\u2013401.","journal-title":"Orthop Traumatol Surg Res OTSR"},{"key":"1207_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12957-022-02510-8","volume":"20","author":"X Hou","year":"2022","unstructured":"Hou X, Du C, Lu L, et al. Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells. World J Surg Oncol. 2022;20:37.","journal-title":"World J Surg Oncol"},{"key":"1207_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00763-x","author":"R Arafeh","year":"2024","unstructured":"Arafeh R, Shibue T, Dempster JM, Hahn WC, Vazquez F. The present and future of the cancer dependency map. Nat Rev Cancer. 2024. https:\/\/doi.org\/10.1038\/s41568-024-00763-x.","journal-title":"Nat Rev Cancer"},{"key":"1207_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s43018-019-0018-6","volume":"1","author":"SM Corsello","year":"2020","unstructured":"Corsello SM, Nagari RT, Spangler RD, et al. Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling. Nat Cancer. 2020;1:235\u201348.","journal-title":"Nat Cancer"},{"key":"1207_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.7171\/jbt.18-2902-002","volume":"29","author":"A Bairoch","year":"2018","unstructured":"Bairoch A. The cellosaurus, a cell-line knowledge resource. J Biomol Tech. 2018;29:25\u201338.","journal-title":"J Biomol Tech"},{"key":"1207_CR18","unstructured":"Tanabe H, Takada Y, Minegishi D, Kurematsu M, Masui T, Mizusawa H. Cell line individualization by STR multiplex system in the cell bank found cross-contamination between ECV304 and EJ-1\/T24. \u7d44\u7e54\u57f9\u990a\u7814\u7a76. 1999;18:329\u201338."},{"key":"1207_CR19","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/ng.2814","volume":"45","author":"S Behjati","year":"2013","unstructured":"Behjati S, Tarpey PS, Presneau N, et al. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet. 2013;45:1479\u201382.","journal-title":"Nat Genet"},{"key":"1207_CR20","unstructured":"Organisation mondiale de la sant Cidrslc. Soft tissue and bone tumours. 2020."},{"key":"1207_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0165-4608(93)90080-6","volume":"69","author":"JA Bridge","year":"1993","unstructured":"Bridge JA, Bhatia PS, Anderson JR, Neff JR. Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions. Cancer Genet Cytogenet. 1993;69:79\u201390.","journal-title":"Cancer Genet Cytogenet"},{"key":"1207_CR22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/gcc.10012","volume":"33","author":"N Mandahl","year":"2002","unstructured":"Mandahl N, Gustafson P, Mertens F, et al. Cytogenetic aberrations and their prognostic impact in chondrosarcoma. Genes Chromosom Cancer. 2002;33:188\u2013200.","journal-title":"Genes Chromosom Cancer"},{"key":"1207_CR23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/path.1023","volume":"196","author":"G Tallini","year":"2002","unstructured":"Tallini G, Dorfman H, Brys P, et al. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the chromosomes and morphology (CHAMP) collaborative study group. J Pathol. 2002;196:194\u2013203.","journal-title":"J Pathol"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-025-01207-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-025-01207-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-025-01207-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T19:04:27Z","timestamp":1746731067000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-025-01207-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["1207"],"URL":"https:\/\/doi.org\/10.1007\/s13577-025-01207-w","relation":{},"ISSN":["1749-0774"],"issn-type":[{"type":"electronic","value":"1749-0774"}],"subject":[],"published":{"date-parts":[[2025,3,24]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict Of interest"}},{"value":"The Ethics Committee of the National Cancer Center (Tokyo, Japan) approved the use of clinical materials in this study (approval number 2004-050).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was provided by the patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"78"}}